Skip to content
Summer 2026 · 26% off every plan with SUMMER26 See pricing
Optionomics
ASIX · 10-Q filed August 7, 2026

ASIX earnings analysis

What we found in ASIX's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.

Our reading of the filing · Free to read, no account needed

AdvanSix reported Q2 2026 revenue of $421.284 million, up 4.3% sequentially and 2.8% year over year, but diluted EPS of $0.19 was substantially below the $0.54 consensus estimate and down from $1.15 a year earlier. The filing does not provide current-quarter gross margin, operating margin, free cash flow, segment results, balance-sheet detail, or quantitative guidance in the supplied text. Floating-rate debt remains a measurable exposure, with a 25-basis-point rate move affecting six-month interest expense by approximately $0.7 million.

What stood out

The parts that mattered.

Pulled out of the filing itself, with the figures the company reported.

Revenue Rebounded Sequentially
Second-quarter revenue was $421.284 million, up approximately 4.3% from $404 million in Q1 2026 and 2.8% from $410 million in Q2 2025.
EPS Improved Sequentially
Reported diluted EPS was $0.19, improving from a $(0.58) loss in Q1 2026.
Disclosure Controls Effective
Management stated that disclosure controls were effective at a reasonable assurance level as of June 30, 2026.
No Control Weakness Identified
No material change in internal control over financial reporting was identified during the quarter ended June 30, 2026.
Repurchase Capacity Remains
The company had approximately $61.958 million of remaining share-repurchase authorization at June 30, 2026, although no shares were repurchased under the program during the quarter.
What to watch

And the other side of it.

The offsets in the same document — the things a summary that only listed the good news would have left out.

Large EPS Miss and Yearly Decline
Second-quarter EPS of $0.19 was 64.81% below the $0.54 consensus estimate and declined from $1.15 in Q2 2025, indicating substantial earnings pressure despite revenue growth.
Floating-Rate Debt Exposure
The company has floating-rate exposure through its Revolving Credit Facility; a 25-basis-point rate fluctuation would have changed six-month interest expense by approximately $0.7 million.
No Updated Risk-Factor Disclosure
The filing says there were no material changes to the risk factors in the 2025 Form 10-K, but it also states that litigation could affect results if a matter became material; no pending claim was expected to have a material adverse effect on consolidated financial position, results, or operating cash flows.
The numbers

What they reported.

What the company itself reported, taken out of the document.

Earnings per share
$0.19
Guidance

What they said about what is next.

The provided 10-Q text contains no quantitative revenue or EPS outlook. Prior-year capital expenditure guidance was discussed in the earlier 8-K, not this filing.

How we read the filing overall

The filing reads worse than the one before it.

One reading of one document. It is not advice, and it is not a forecast.
Earlier filings

What came before.

10-Q · May 8, 2026
AdvanSix reported a strong Q1 2026 with revenues of $404.2 million, marking a 7% increase year-over-year, although it experienced a diluted EPS loss of $(0.58), which missed analyst expectations of $(0.47). The company…
10-K · February 20, 2026
AdvanSix describes a strategy built on a vertically integrated U.S. manufacturing footprint, cost leadership in caprolactam and an expanding Plant Nutrients franchise (SUSTAIN program) to improve through‑cycle…
10-Q · November 7, 2025
AdvanSix reported quarterly sales of $374.5M and a net loss of $2.6M for Q3 2025, driven by severe margin compression. Gross margin fell to ~6.8% and the company recorded an operating loss and diluted EPS of $(0.10),…
10-Q · August 1, 2025
AdvanSix reported quarterly revenue of $410,022,000 for the three months ended June 30, 2025, down 9.6% versus $453,479,000 a year ago, with gross margin compressing to 14.3% from 17.9% and diluted EPS down to $1.15…

This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.

Read the next one first.

We read every filing ASIX makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.

Cancel anytime · Month to month · Switch tiers whenever